The ratings on Boardwalk, Gulf South, and Texas Gas reflect the strong support of Loews. This support was evident most recently with the $620 million acquisition of Louisiana Midstream, which included the purchase of 65% of assets on an interim basis by a joint venture between a wholly-owned subsidiary of Loews and Boardwalk. In late October 2013, Boardwalk then raised equity and purchased the interest held by the Loews subsidiary. This follows Boardwalk's $550 million acquisition of storage assets in late 2011. A wholly-owned Loews subsidiary purchased 80% of the assets through a joint venture and, in early 2012, Boardwalk acquired that interest, which was largely funded with equity proceeds.
Loews showed significant support to Boardwalk during the nearly $5 billion pipeline expansion projects that reached their peak financing needs in 2008 and 2009. Loews provided $200 million of subordinated debt and $1.35 billion in equity, $700 million of which was in the form of low-distribution-paying Class B units that converted to common units in October 2013.
Sentiment: Strong Buy
Your sub penny rant shows you are just looking for a cheaper entry. lol
Sub penny is the pump and dump pink 1 man company with a billion shares o/s
30 day turns into 90 day minimum and a lot can happen in that time.
You think the boys who put 7M into CBLI at $1.20 are going to let that happen... not a chance.
BUFFALO, N.Y., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that it has entered into definitive agreements with two institutional investors to purchase an aggregate of $7 million of its common stock in an at-the-market registered direct offering at $1.22 per share. Additionally, for each share of common stock purchased, investors will receive a Series A Warrant to purchase one-half of a share of our common stock at an exercise price of $1.22 per share, which shall be initially exercisable six months following issuance and expire five years from the date of issuance, and a Series B Warrant to purchase one-half of a share of our common stock at an exercise price of $1.22 per share, which shall be initially exercisable six months following issuance and expire 18 months from the date of issuance. The closing of the offering is expected to take place on or about January 16, 2014, subject to the satisfaction of customary closing conditions.